Hyperemia

Search with Google Search with Bing
Information
Disease name
Hyperemia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00268554 Completed N/A Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole December 2005 July 2006
NCT01642147 Completed N/A Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy November 2012 January 2013
NCT01959230 Completed Phase 3 Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness November 7, 2013 December 20, 2013
NCT01959243 Completed Phase 3 Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants February 22, 2014 June 23, 2014
NCT02039765 Completed Phase 1 Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. February 2014 April 2014
NCT02136589 Completed Phase 4 Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes September 2008 December 2008
NCT05706181 Recruiting Phase 1/Phase 2 Heat Therapy, Functional Capacity, and Vascular Health in Older Adults November 3, 2022 July 30, 2026
NCT02183779 Unknown status N/A PORH and Response to Cold in Raynaud's Phenomenon. June 2014 June 2017
NCT04132648 Withdrawn Phase 2 Curcumin and Exercise in Chronic Kidney Disease November 15, 2020 November 1, 2021
MeSH unique ID (MeSH (Medical Subject Headings))
D006940